Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Biotechnology

Healthcare
$1.61 -0.87%

-$0.02 today

Market cap
$80.25M
Beta
0.00
P/E (TTM)
-16.7
EPS (TTM)
-$0.14
52W Low $2.01High $48.91

Volume 0.02M

Average 0.34M

Fair Value & DCF

Compare our fair value with your own assumptions

Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.

Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Intrinsic Alpha fair value

Locked

Current Price

$1.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.

Build your own valuation

Test an independent scenario and compare it with Intrinsic Alpha's estimate.

Sign in to use the DCF calculator

Free accounts get 5 valuations per week. Upgrade for more.

Sign in / Sign up

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Estimates & History

Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.

Further estimates hidden. Sign in to unlock

Competitor Valuations

Peer stocks ranked by intrinsic value status

CompanyMarket CapPriceValuationP/E1Y Return

Jade Biosciences, Inc.

NASDAQ:JBIO

$1.03B$16.14Not rated-7.4+24.32%

Crescent Biopharma, Inc.

NASDAQ:CBIO

$525.59M$14.15Not rated-3.3-4.83%

Lyell Immunopharma, Inc.

NASDAQ:LYEL

$351.57M$14.30Not rated-1.1-19.34%

AN2 Therapeutics, Inc.

NASDAQ:ANTX

$172.64M$4.55Not rated-4.9+358.33%

Foghorn Therapeutics Inc.

NASDAQ:FHTX

$124.12M$2.07Not rated-3.8-63.17%

Kalaris Therapeutics Inc

NASDAQ:KLRS

$37.49M$1.58Not rated-2.5-65.57%

Pelthos Therapeutics Inc.

AMEX:PTHS

$29.25M$7.44Not rated-0.7-44.89%